Labetalol injection contraindications: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
Labetalol HCl injection is contraindicated in [[bronchial asthma]], overt cardiac failure, greater than first degree heart block, cardiogenic shock, severe [[bradycardia]], other conditions associated with severe and prolonged [[hypotension]], and in patients with a history of [[hypersensitivity]] to any component of the product (see WARNINGS). | Labetalol HCl injection is contraindicated in [[bronchial asthma]], overt cardiac failure, greater than first degree heart block, cardiogenic shock, severe [[bradycardia]], other conditions associated with severe and prolonged [[hypotension]], and in patients with a history of [[hypersensitivity]] to any component of the product (see WARNINGS). | ||
Beta-blockers, even those with apparent cardioselectivity, should not be used in patients with a history of obstructive airway disease, including [[asthma]]. | Beta-blockers, even those with apparent cardioselectivity, should not be used in patients with a history of obstructive airway disease, including [[asthma]].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=abfc6b75-1ed5-41f1-0484-4597488237bc | publisher = | date = | accessdate = 5 February 2014 }}</ref> | ||
Revision as of 17:57, 5 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
Contraindications
Labetalol HCl injection is contraindicated in bronchial asthma, overt cardiac failure, greater than first degree heart block, cardiogenic shock, severe bradycardia, other conditions associated with severe and prolonged hypotension, and in patients with a history of hypersensitivity to any component of the product (see WARNINGS).
Beta-blockers, even those with apparent cardioselectivity, should not be used in patients with a history of obstructive airway disease, including asthma.[1]
References
- ↑ "LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.]". Retrieved 5 February 2014.